KalVista Pharmaceuticals, Inc. (KALV)

26.74 +0.02 (+0.07%) USD  |  NASDAQ  |  May 07, 09:42
More

KalVista Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for KALV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade